Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 74.50
-0.75 (-1.00%)
Apr 29, 2026, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 22.17 billion as of April 29, 2026. Its market cap has increased by 67.23% in one year.
Market Cap
22.17B
Enterprise Value
20.91B
Revenue
797.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.50
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 22.17B, an increase of 20.30%. That is a compound annual growth rate of 3.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 22.17B | 40.79% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 23.21B |
| Zai Lab | 20.04B |
| Duality Biotherapeutics | 25.45B |
| Ascletis Pharma | 19.00B |
| Shanghai Bao Pharmaceuticals | 26.78B |
| InnoCare Pharma | 28.40B |
| Ascentage Pharma Group International | 16.97B |
| Nanjing Leads Biolabs | 16.80B |